TRILLIUM THERAPEUTICS INC

CUSIP: 89620X506 Class: COM NEW

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 850,207 Value ($000) $14,929 Avg Close Range
Q2 2021
Shares 839,889 Value ($000) $8,146 Avg Close Range
Q1 2021
Shares 73,562 Value ($000) $810 Avg Close Range
Q4 2020
Shares 71,457 Value ($000) $1,073 Avg Close Range
Q3 2020
Shares 15,662 Value ($000) $222 Avg Close Range
Q2 2020
Shares 17,248 Value ($000) $139 Avg Close Range
Q1 2020
Shares 17,248 Value ($000) $69 Avg Close Range
Q4 2019
Shares 102,725 Value ($000) $105 Avg Close Range
Q3 2019
Shares 102,725 Value ($000) $31 Avg Close Range
Q2 2019
Shares 102,725 Value ($000) $33 Avg Close Range
Q1 2019
Shares 26,627 Value ($000) $17 Avg Close Range
Q4 2018
Shares 26,627 Value ($000) $45 Avg Close Range
Q3 2018
Shares 10,086 Value ($000) $58 Avg Close Range
Q2 2018
Shares 10,086 Value ($000) $60 Avg Close Range